Theralink Technologies, Inc. announced the appointment of Faith Zaslavsky, a seasoned genomics commercial leader, as its President & Chief Operating Officer effective December 5, 2022. The Company's Theralink test is breakthrough technology, protected by nine patents, which is the next step beyond genomics. Faith has most recently held the position of President of Oncology for a $150 million division of a life sciences company pioneering in the genomic space.

Her responsibilities included overseeing all commercials functions which include leading Medical Services, Medical Affairs, National and Enterprise Accounts, and Sales & Marketing. Ms. Zaslavsky has spent 22 years leading and transforming teams, designing solutions for physicians to support care, and advocating for patients facing a journey with cancer. In previous roles she served as the General Manager of Oncology, National Sales Director, Regional Sales Director, Regional Managed Care Director, and Regional Area Manager.

Ms. Zaslavsky's talents and expertise are in forming large high performing multifunctional teams, strategic planning, cross functional alignment designing impactful patient centric health system partnerships and delivering results through proper P&L management. Faith also serves on the Board of Directors for the American Society of Breast Surgeons Foundation as well as non-profit organizations focusing on children's development. She received her bachelor's degree in Business Administration from Washington State University.